Correspondence Activity Detail
Nuvectis Pharma, Inc. (NVCT) (CIK 0001875558) (NVCT)
Activity window: Oct. 25, 2025 to Oct. 24, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
Probe Score Breakdown
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted
8-K adjustment, capped at 10.0. This is the 365-day
v1 snapshot. Computed:
Oct. 24, 2026.
Latest filing activity:
Feb. 18, 2026.
These dates describe different events.
Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
| Feb. 18, 2026 |
CORRESP |
Neutral/Informational |
Moderate |
Nuvectis Pharma, Inc. has submitted a request to the SEC to accelerate the effective date of its Registration Statement on Form S-3. The company aims for the registration to becom… |
Read Filing
EDGAR
|
| Feb. 18, 2026 |
UPLOAD |
Neutral/Informational |
Low |
The SEC correspondence dated February 18, 2026, informs Nuvectis Pharma, Inc. that their registration statement on Form S-3, filed on February 13, 2026, will not be reviewed by th… |
Read Filing
EDGAR
|
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.